Skip to menu Skip to content Skip to footer

2020

Journal Article

The cystic fibrosis gut as a potential source of multidrug resistant pathogens

Taylor, Steven L., Leong, Lex E. X., Sims, Sarah K., Keating, Rebecca L., Papanicolas, Lito E., Richard, Alyson, Mobegi, Fredrick M., Wesselingh, Steve, Burr, Lucy D. and Rogers, Geraint B. (2020). The cystic fibrosis gut as a potential source of multidrug resistant pathogens. Journal of Cystic Fibrosis, 20 (3), 413-420. doi: 10.1016/j.jcf.2020.11.009

The cystic fibrosis gut as a potential source of multidrug resistant pathogens

2020

Journal Article

Improving antenatal asthma management: a complex journey

Chen, Clarissa, Meng-Wong Taing, Burr, Lucy, Barrett, Helen L. and Clifton, Vicki L. (2020). Improving antenatal asthma management: a complex journey. EMJ Respiratory, 97-107. doi: 10.33590/emjrespir/20-00143

Improving antenatal asthma management: a complex journey

2020

Conference Publication

The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting

Lee, Annemarie, Smith, Rebecca, Osadnik, Christian, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Jayaram, Lata, King, Paul, Middleton, Peter, Morgan, Lucy, Tu Nguyen, , Smith, Daniel, Stroil-Salama, Enna, Thomson, Rachel, Waring, Justin, Waterer, Grant, Wong, Conroy and Mcaleer, Rachel (2020). The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting. ERS International Congress 2020, Online, 7–9 September 2020. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2020.76

The educational needs of people with bronchiectasis in a pulmonary rehabilitation setting

2020

Conference Publication

Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries

Shoemark, Amelia, Finch, Simon, Torres, Antoni, Elborn, Stuart, Ringhausen, Felix, De Soyza, Anthony, Aliberti, Stefano, Blasi, Francesco, Dimakou, Katerina, Haworth, Charles, Hill, Adam, Loebinger, Michael, Vendrell, Montse, Welte, Tobias, Wilson, Robert, Crichton, Megan, Goeminne, Pieter, Burgel, Pierre-Regis, Polverino, Eva, Dhar, Raja, Singh, Sheetu, Talwar, Deepak, Mohan, Murali, Tripathi, Surya Kant, Swarnakar, Rajesh, Trivedi, Sonali, Rajagopala, Srinivas, D'Souza, George, Admanabhan, Arjun P. ... Chalmers, James D. (2020). Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries. International Congress of the European-Respiratory-Society (ERS), Electr Network, Sep 07-09, 2020. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2020.3335

Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries

2020

Conference Publication

Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance

Keating, R. and Burr, L. (2020). Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC, Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance

2020

Conference Publication

Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases

Wang, Y., Taylor, S., Basham, J., Keating, R., Hindmarsh, K., Choo, J., Wesselingh, S., Burr, L. and Rogers, G. (2020). Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases

2020

Conference Publication

Does gene modulation therapy improve glucose control in cystic fibrosis?

Keating, R., Burr, L. and Barrett, H. (2020). Does gene modulation therapy improve glucose control in cystic fibrosis?. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons.

Does gene modulation therapy improve glucose control in cystic fibrosis?

2020

Conference Publication

Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study

Burr, L., Megan, M. and Simon, B. (2020). Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC, Australia, 27-31 March 2020. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.13777

Sustained effect of macrolide on sputum volume in bronchiectasis. The bless infinity study

2020

Journal Article

Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis

Ramsey, Kathryn A., Chen, Alice C. H., Radicioni, Giorgia, Lourie, Rohan, Martin, Megan, Broomfield, Amy, Sheng, Yong H., Hasnain, Sumaira Z., Radford-Smith, Graham, Simms, Lisa A., Burr, Lucy, Thornton, David J., Bowler, Simon D., Livengood, Stephanie, Ceppe, Agathe, Knowles, Michael R., Noone, Peadar G., Donaldson, Scott H., Hill, David B., Ehre, Camille, Button, Brian, Alexis, Neil E., Kesimer, Mehmet, Boucher, Richard C. and McGuckin, Michael A. (2020). Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 201 (6), 661-670. doi: 10.1164/rccm.201906-1219OC

Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis

2020

Conference Publication

Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection

Hasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777

Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection

2020

Journal Article

Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence Taskforce

Vogel, Joshua P., Tendal, Britta, Giles, Michelle, Whitehead, Clare, Burton, Wendy, Chakraborty, Samantha, Cheyne, Saskia, Downton, Teena, Fraile Navarro, David, Gleeson, Glenda, Gordon, Adrienne, Hunt, Jenny, Kitschke, Jackie, McDonald, Steven, McDonnell, Nolan, Middleton, Philippa, Millard, Tanya, Murano, Melissa, Oats, Jeremy, Tate, Rhiannon, White, Heath, Elliott, Julian, Roach, Vijay, Homer, Caroline S.E., McGowan, Sharon, Ballenden, Nicola, Barrett, Terri-Lee, Beavis, Vanessa, Saunders, James Beckford ... National COVID-19 Clinical Evidence Taskforce (2020). Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence Taskforce. Australian and New Zealand Journal of Obstetrics and Gynaecology, 60 (6) ajo.13270, 840-851. doi: 10.1111/ajo.13270

Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence Taskforce

2019

Journal Article

Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?

Visser, Simone K., Bye, Peter T. P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?. Lung, 197 (6), 803-810. doi: 10.1007/s00408-019-00280-x

Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?

2019

Journal Article

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis

Chalmers, James D, Boersma, Wim, Lonergan, Mike, Jayaram, Lata, Crichton, Megan L, Karalus, Noel, Taylor, Steven L, Martin, Megan L, Burr, Lucy D, Wong, Conroy and Altenburg, Josje (2019). Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respiratory Medicine, 7 (10), 845-854. doi: 10.1016/s2213-2600(19)30191-2

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis

2019

Conference Publication

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis

Tong, Koliarne, Dorahy, Douglas, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Barker, Daniel and Wark, Peter (2019). A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA2126

A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis

2019

Conference Publication

Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis

Altenburg, Josje, Chalmers, James, Lonergan, Mike, Jayaram, Lata, Burr, Lucy, Crichton, Megan, Karalus, Noel, Martin, Megan, Taylor, Steven, Wong, Conroy and Boersma, Wim (2019). Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA4945

Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis

2019

Journal Article

The impact of CFTR modulator therapies on CF airway microbiology

Rogers, Geraint B., Taylor, Steven L., Hoffman, Lucas R. and Burr, Lucy D. (2019). The impact of CFTR modulator therapies on CF airway microbiology. Journal of Cystic Fibrosis, 19 (3), 359-364. doi: 10.1016/j.jcf.2019.07.008

The impact of CFTR modulator therapies on CF airway microbiology

2019

Journal Article

Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry

Visser, Simone K., Bye, Peter T.P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry. Respiratory Medicine, 155, 97-103. doi: 10.1016/j.rmed.2019.07.016

Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry

2019

Conference Publication

Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients

Thomson, R., Scoleri, G., Taylor, S., Leong, L., Burr, L. and Rogers, G. (2019). Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1035

Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients

2019

Journal Article

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

Tong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

2018

Journal Article

Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut

Wang, Yanan, Leong, Lex E.X., Keating, Rebecca L., Kanno, Tokuwa, Abell, Guy C.J., Mobegi, Fredrick M., Choo, Jocelyn M., Wesselingh, Steve L., Mason, A. James, Burr, Lucy D. and Rogers, Geraint B. (2018). Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes, 10 (3), 1-15. doi: 10.1080/19490976.2018.1534512

Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut